by Keishi Foecke | May 1, 2025 | Blog Post
As the need for more effective and accessible obesity medicines grows, mergers and acquisitions (M&A) have emerged as a key strategy for life science companies of all sizes to accelerate innovation and competition to bring new treatment options to patients....
by Keishi Foecke | Apr 23, 2025 | Blog Post
Mergers and acquisitions (M&A) in America’s life sciences industry not only play a critical role in bringing new breakthroughs to patients, but also strengthen state economies across the country. Life sciences M&A plays a pivotal role in fueling innovation,...
by Keishi Foecke | Apr 16, 2025 | Blog Post
A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) highlights the unique and fundamental role of mergers and acquisitions (M&A) in driving innovation across America’s biopharmaceutical industry. This new resource includes key insights...
by Keishi Foecke | Apr 3, 2025 | Blog Post
The American life sciences ecosystem operates in one of the most complex and high-risk investment environments. With more than 80% of life sciences companies operating without a profit, external investment—including from venture capital (VC)—is often critical to...
by Keishi Foecke | Mar 25, 2025 | Blog Post
For decades, mergers and acquisitions (M&A) have fueled the development and delivery of breakthrough treatments for complex diseases with a high unmet need. A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) spotlights this unique and...
by Keishi Foecke | Mar 19, 2025 | Blog Post
New resources from the Partnership for the U.S. Life Science Ecosystem (PULSE) highlight the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. Life sciences M&A represents a critical pathway for companies of all...
